机译:佐剂曲妥珠单抗对乳房切除术治疗人体表皮生长因子受体2阳性乳腺癌型型患者的影响
Mem Sloan Kettering Canc Ctr Dept Radiat Oncol New York NY 10021 USA;
Mem Sloan Kettering Canc Ctr Dept Surg New York NY 10021 USA;
Mem Sloan Kettering Canc Ctr Dept Radiat Oncol New York NY 10021 USA;
Mem Sloan Kettering Canc Ctr Dept Med New York NY 10021 USA;
Mem Sloan Kettering Canc Ctr Dept Med New York NY 10021 USA;
Mem Sloan Kettering Canc Ctr Dept Surg New York NY 10021 USA;
Mem Sloan Kettering Canc Ctr Dept Surg New York NY 10021 USA;
Mem Sloan Kettering Canc Ctr Dept Radiat Oncol New York NY 10021 USA;
Mem Sloan Kettering Canc Ctr Dept Radiat Oncol New York NY 10021 USA;
Mem Sloan Kettering Canc Ctr Dept Biostat &
Epidemiol New York NY 10021 USA;
Mem Sloan Kettering Canc Ctr Dept Biostat &
Epidemiol New York NY 10021 USA;
Mem Sloan Kettering Canc Ctr Dept Radiat Oncol New York NY 10021 USA;
Mem Sloan Kettering Canc Ctr Dept Radiat Oncol New York NY 10021 USA;
Mem Sloan Kettering Canc Ctr Dept Radiat Oncol New York NY 10021 USA;
Mem Sloan Kettering Canc Ctr Dept Radiat Oncol New York NY 10021 USA;
机译:辅助曲妥珠单抗对乳房切除术治疗的人表皮生长因子受体2-阳性乳腺癌局部复发的影响
机译:辅助曲妥珠单抗可减少接受保乳疗法治疗淋巴结阴性,人表皮生长因子受体2阳性乳腺癌的女性的局部复发
机译:人表皮生长因子受体2阳性乳腺癌复发辅助曲妥珠单抗:复发,治疗和结局的模式。
机译:人类表皮生长因子受体2拮抗剂在二氧化硅中用于印尼治疗的印尼植物化学成分的鉴定。
机译:与人表皮生长因子受体阳性(HER2 +)转移性乳腺癌相关的间接成本
机译:曲妥珠单抗氨丹宁在仅使用过曲妥珠单抗和帕妥珠单抗联合曲妥珠单抗治疗且仅在日本人群中治疗的转移性人类表皮生长因子受体2阳性乳腺癌患者之间的疗效比较
机译:佐剂曲妥珠单抗降低了接受淋巴结阴性的哺乳治疗的妇女的患者患者,人表皮生长因子受体2阳性乳腺癌